Dual Roles of IL-15 in Cancer Biology

@inproceedings{Fabbi2016DualRO,
  title={Dual Roles of IL-15 in Cancer Biology},
  author={Marina Fabbi and Silvano Ferrini},
  year={2016}
}
IL-15 is an immune-enhancing cytokine belonging to the IL-2 family, which supports survival, proliferation and functional activities of NK, NK-T, T and B cells. Moreover, IL-15 may support the growth and survival of different lymphoid malignancies, suggesting that targeting of the IL-15/IL-15R system or its downstream signaling cascade may result in therapeutic effects, in these tumors. On the other hand, given its immune-enhancing activities IL-15 has been considered a good candidate for… 

Figures from this paper

Programming CAR T cells to enhance anti-tumor efficacy through remodeling of the immune system

This review focuses on the recent advances in the engineering of CAR T cell therapies to restore the immune response in solid malignancies, especially with CAR T cells acting as cellular carriers to deliver immunomodulators to tumors to mobilize the endogenous immune response.

SARS-CoV-2 B.1.1.7 and B.1.351 variants of concern induce lethal disease in K18-hACE2 transgenic mice despite convalescent plasma therapy

In this study, infectivity and immune responses triggered by VoCs were defined and observed that early 2020 SARS-CoV-2 human immune plasma was insufficient to protect against challenge with B.1.1-351 in the mouse model.

References

SHOWING 1-10 OF 97 REFERENCES

Immunotherapeutic applications of IL-15.

Clinical trials of IL-15 have been initiated in cancer patients and in HIV vaccination and will elucidate the potential ofIL-15-based immunotherapy, which is reinforced by its low toxicity and efficacy in preclinical tumor models.

Molecular Pathways: Interleukin-15 Signaling in Health and in Cancer

An overview of the molecular events in the IL-15 signaling pathway and the aberrancies in its regulation that are associated with chronic inflammation and cancer is provided.

High antitumor activity of RLI, an interleukin-15 (IL-15)–IL-15 receptor α fusion protein, in metastatic melanoma and colorectal cancer

It is shown that RLI has a higher efficiency than IL-15 or IL-2 to reduce lung and liver metastasis and enhance survival in the mouse B16F10 melanoma model, a result that was associated with a higher half-life in vivo.

Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model

Combining the immune stimulatory properties of IL-15 with simultaneous removal of two critical immune inhibitory checkpoints showed enhancement of immune responses, leading to increased antitumor activity.

Simultaneous Blockade of Multiple Immune System Inhibitory Checkpoints Enhances Antitumor Activity Mediated by Interleukin-15 in a Murine Metastatic Colon Carcinoma Model

Combining the immune stimulatory properties of IL-15 with the simultaneous removal of 2 critical immune system inhibitory checkpoints showed enhancement of immune responses leading to increased antitumor activity.

Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer

The scientific basis for clinical trials using the combination regimen of IL-15 with an anti-CD40 antibody with greater therapeutic efficacy is provided, as demonstrated by prolonged survival of the mice compared with either mIL-15 or the anti- CD40 antibody-alone groups.

Safety and immunologic effects of IL-15 administration in nonhuman primates.

It is demonstrated in nonhuman primates that IL-15 administration expands memory CD8(+) and CD4(+) T cells, and natural killer cells in the peripheral blood, with minimal increases in CD4 (+)CD25(+)Foxp3(+) regulatory T cells.

Soluble Interleukin-15 Complexes Are Generated In Vivo by Type I Interferon Dependent and Independent Pathways

It is shown that type I IFNs, VSV infection, and CD40 stimulation induce sIL-15 complexes suggesting the generation of sIL -15 complexes is a common event associated with immune activation.

IL-15 deficient Tax mice reveal a role for IL-1α in tumor immunity

Findings identify IL-15 and IL-1a as therapeutic targets in lymphoma and reveal a unique transcriptional profile in tumor cells that arise in the absence of IL- 15 that included a significant increase in the expression of IL,1a and IL -1a-regulated cytokines.

IL-15 suppresses colitis-associated colon carcinogenesis by inducing antitumor immunity

Evidence is provided that IL-15 suppresses colitis-associated colon carcinogenesis through regulation of antitumor cytotoxicity, and modulation of the inflammatory tumor micromilieu.
...